Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
Scientific Article
/ Nov 20, 2020
Insight into Amorphous Solid Dispersion Dissolution Behavior: Laser-Diffraction and Raman Spectroscopy Holding Hands
Read more
Scientific Article
/ Nov 20, 2020
Leveraging Hollow Fibre Membranes and High Boiling Point Organic Solvents in the Production of Enteric Amorphous Solid Dispersions
Read more
Scientific Article